Cargando…
Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study
There are currently no reliable, established serum biomarkers to predict the prognosis of radiotherapy for advanced cervical cancer. We aimed to identify serum biomarkers for survival after radiotherapy for cervical cancer. In this multicenter prospective cohort study, the usefulness of pre- and pos...
Autores principales: | Harima, Yoko, Ariga, Takuro, Kaneyasu, Yuko, Ikushima, Hitoshi, Tokumaru, Sunao, Shimamoto, Shigetoshi, Takahashi, Takeo, Ii, Noriko, Tsujino, Kayoko, Saito, Anneyuko I., Ushijima, Hiroki, Toita, Takafumi, Ohno, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562853/ https://www.ncbi.nlm.nih.gov/pubmed/34727105 http://dx.doi.org/10.1371/journal.pone.0259235 |
Ejemplares similares
-
Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients
por: Ohno, Tatsuya, et al.
Publicado: (2017) -
Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers
por: Murakami, Naoya, et al.
Publicado: (2022) -
Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group
por: Ikushima, Hitoshi, et al.
Publicado: (2021) -
A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan
por: Kaneyasu, Yuko, et al.
Publicado: (2021) -
Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study
por: Ariga, Takuro, et al.
Publicado: (2015)